UpHealth, Inc.
UPHLHealthcare · Services-Health Services · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|
| Revenue | $130.0M | $158.8M | $123.8M | $5.4M | — |
| Operating income | −$89.6M | −$161.4M | −$380.0M | −$1.9M | −$953,436 |
| Net income | −$57.8M | −$223.0M | −$341.0M | −$2.2M | $360,451 |
| Total assets | $231.8M | $339.8M | $569.3M | $262.4M | $175.8M |
| Total liabilities | $176.7M | $233.7M | $235.5M | $41.7M | $339,958 |
| Equity | $55.1M | $105.1M | $318.5M | $220.7M | $5.0M |
| EPS (diluted) | $-3.26 | $-15.17 | $-31.86 | $-0.04 | — |
| Shares out. | 16.8M | 144.5M | 19.8M | 22.2M | 5.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −68.9%
- Net margin
- −44.5%
- Return on equity
- −105.0%
- Return on assets
- −25.0%
- Return on capital (ROCE)
- −43.7%
- Liabilities / assets
- 76.2%
- Debt / equity
- 3.21×
- Book value / share
- $3.28
- Revenue growth (YoY)
- −18.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -11.23distress
- Accruals / assets
- −17.3%clean
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2026
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2026
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2025
- NT 10-Qmissed a reporting deadline ↗May 15, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Rey-Giraud AgnesDirector | May 21, 2024 | Sell | 500 | $0.61 |
| Greene James SDirector | Jan 31, 2024 | Grant | 100,000 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 7,189 | 23.6 | 0.0% |
| Apr 30, 2026 | 7,189 | 3.8 | 0.0% |
| Apr 15, 2026 | 7,189 | 3.4 | 0.0% |
| Mar 31, 2026 | 7,189 | 22.5 | 0.0% |
| Mar 13, 2026 | 7,189 | 1.0 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventSep 27, 2024
- Other material eventSep 26, 2024
- Other material eventAug 27, 2024
- Director / officer change · Other material eventJul 15, 2024
- Other material eventJun 6, 2024
- Regulation FD disclosureMay 20, 2024
- Other material eventMay 10, 2024
- Other material eventApr 15, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.